|
FAM122B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21019999999683E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.656140E-03 |
| Normal-vs-Stage2 |
1.665720E-02 |
| Normal-vs-Stage3 |
4.70270000052508E-07 |
| Normal-vs-Stage4 |
2.14849999999878E-05 |
| Stage1-vs-Stage2 |
5.702400E-01 |
| Stage1-vs-Stage3 |
4.924400E-03 |
| Stage1-vs-Stage4 |
3.418200E-02 |
| Stage2-vs-Stage3 |
1.882030E-01 |
| Stage2-vs-Stage4 |
2.544000E-01 |
| Stage3-vs-Stage4 |
9.658000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81170000002062E-06 |
| Normal-vs-AfricanAmerican |
1.423640E-01 |
| Normal-vs-Asian |
7.192100E-02 |
| Caucasian-vs-AfricanAmerican |
5.003200E-01 |
| Caucasian-vs-Asian |
1.052390E-01 |
| AfricanAmerican-vs-Asian |
6.685600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91809999999992E-05 |
| Normal-vs-Female |
1.046210E-04 |
| Male-vs-Female |
3.368600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.262400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.3790000000028E-05 |
| Normal-vs-Age(61-80Yrs) |
1.14839999998395E-06 |
| Normal-vs-Age(81-100Yrs) |
5.095700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.452820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.800400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.316500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.996990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.240800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.444000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.663740E-03 |
| Classical-VS-Follicular |
5.429000E-01 |
| Classical-VS-Other |
7.934400E-01 |
| Classical-VS-Normal |
2.603000E-03 |
| Tall-VS-Follicular |
9.376100E-03 |
| Tall-VS-Other |
5.965700E-02 |
| Tall-VS-Normal |
3.13789999983882E-07 |
| Follicular-VS-Other |
6.888600E-01 |
| Follicular-VS-Normal |
6.059300E-03 |
| Other-VS-Normal |
3.713800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86370000000635E-05 |
| Normal-vs-N1 |
1.459310E-03 |
| N0-vs-N1 |
9.911800E-01 |
|
|
